McBrayer, Samuel K <br/><br/>
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.  [electronic resource] 

 -  Blood  May 2012 
 - 4686-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2011-09-377846  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biological Availability<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cell Survival--genetics<br/>Cells, Cultured<br/>Disease Progression<br/>Drug Evaluation, Preclinical<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glucose--metabolism<br/>Glucose Transport Proteins, Facilitative--antagonists & inhibitors<br/>Glucose Transporter Type 4--antagonists & inhibitors<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>Molecular Targeted Therapy--methods<br/>Multiple Myeloma--genetics<br/>Off-Label Use<br/>Primary Cell Culture<br/>Ritonavir--pharmacology